2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow TEPEZZA: new trials by email Literature Review of TEPEZZA trials Research Report on TEPEZZA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study Teprotumumab, Placebo - Thyroid Eye Disease | Phase 4 | Completed | Amgen | 313 | 2021-09-16 | 2026-08-21 |
| A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease TEPEZZA, Placebo - Thyroid Eye Disease, Chronic (Inactive) Thyroid Eye Disease | Phase 4 | Completed | Amgen | 62 | 2021-09-02 | 2024-07-01 |
Graves Ophthalmopathy (2) · Bronchiolitis Obliterans Syndrome (1) · Exophthalmos (1) · Sedentary Behavior (1)
Amgen (2)
United States (2) · France (1) · Germany (1) · Italy (1) · Spain (1) · United Kingdom (1)